Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

Nom du journal : Invest New Drugs

Année : 2009

Volume : 7

Page de départ : 482

Page de fin : 489

Auteurs: Fayette J, Penel N, Chevreau C, Blay JY, Cupissol D, Thyss A, Guillemet C, Rios M, Rolland F, Fargeot P, Bay JO, Mathoulin-Pélissier S, Coindre JM, Bui BN, Yamori T,